Cyclerion Therapeutics, Inc. - stock earnings
CYCN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 7.6 million USD | ? USD |
| 2023Q2 | -4.2 million USD | ? USD |
| 2023Q1 | -6.8 million USD | ? USD |
| 2022Q4 | -7.0 million USD | 1.6 million USD |
| 2022Q3 | -10.3 million USD | ? USD |
| 2022Q2 | -13.3 million USD | 72000 USD |
| 2022Q1 | -13.0 million USD | 225000 USD |
| 2021Q4 | -10.8 million USD | 182000 USD |
| 2021Q3 | -11.3 million USD | 77000 USD |
| 2021Q2 | -16.2 million USD | 3.0 million USD |
| 2021Q1 | -13.4 million USD | 62000 USD |
| 2020Q4 | -19.2 million USD | 133000 USD |
| 2020Q3 | -18.8 million USD | 400000 USD |
| 2020Q2 | -19.5 million USD | 749000 USD |
| 2020Q1 | -20.2 million USD | 1.0 million USD |
| 2019Q4 | -26.1 million USD | 1.5 million USD |
| 2019Q3 | -27.3 million USD | 1.4 million USD |
| 2019Q2 | -32.3 million USD | 1.6 million USD |
| 2019Q1 | -37.4 million USD | ? USD |
| 2018Q4 | -30.9 million USD | ? USD |
| 2018Q3 | -29.3 million USD | ? USD |
| 2018Q2 | -29.8 million USD | ? USD |
| 2018Q1 | -25.3 million USD | ? USD |
CYCN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.8 million USD | ? USD |
| 2022 | -43.8 million USD | 297000 USD |
| 2021 | -51.7 million USD | 3.3 million USD |
| 2020 | -72.7 million USD | 2.3 million USD |
| 2019 | -121.0 million USD | 4.5 million USD |
| 2018 | -115.3 million USD | ? USD |
| 2017 | -93.9 million USD | ? USD |
| 2016 | -63.6 million USD | ? USD |
CYCN
Price: $2.82
52 week price:
Earnings Per Share: -5.39 USD
P/E Ratio: -0.20
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 146600
Market Capitalization: 8.3 million